You are here

Nova Mentis Life Science Corp.

Nova Mentis Life Science Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NOVA
CSE Index: 
Currency: 

Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Their mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome.

You are here

Nova Mentis Life Science Corp. (NOVA)

SEDAR Information

Company Info

Address
700-838 W Hastings Street
Vancouver, BC V6C 0A6
Canada
Phone
778-819-0244
Email
info@novamentis.ca
Website
http://www.novamentis.ca
Listing date
Tuesday, February 10, 2015
Transfer Agent
Olympia Trust Company
Investor Relations
William Rascan
Email
info@novamentis.ca
Auditor
Kreston GTA LLP

Capitalization

Issued & Outstanding: 
148168660
Reserved for Issuance: 
12848000

Company Officers

Will Rascan, Chief Executive Officer
Kelly Pladson, Corporate Secretary
Rebecca Hudson, Chief Financial Officer
Derek Ivany, Executive Chair

Bulletins

25/06/2020

2020-0644 – Name and Symbol Change and Consolidation - Liberty Leaf Holdings Ltd. (LIB)

le 25 juin/June 2020

Liberty Leaf Holdings Ltd. has announced a name change and symbol change to Nova Mentis Life Science Corp. (NOVA) and a consolidation of its issued and outstanding common shares on the basis of one (1) post consolidated common share for every four (4) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 60,881,533 common shares.

The shares will begin trading on a consolidated basis and with a new CUSIP number on June 26, 2020.